Cargando…

Evaluation of a visual interpretation method for tau‐PET with (18)F‐flortaucipir

INTRODUCTION: Positron emission tomography targeting tau (tau‐PET) is a promising diagnostic tool for the identification of Alzheimer's disease (AD). Currently available data rely on quantitative measures, and a visual interpretation method, critical for clinical translation, is needed. METHODS...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sonni, Ida, Lesman Segev, Orit H., Baker, Suzanne L., Iaccarino, Leonardo, Korman, Deniz, Rabinovici, Gil D., Jagust, William J., Landau, Susan M., La Joie, Renaud
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Neuroimaging
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7699207/ https://www.ncbi.nlm.nih.gov/pubmed/33313377 http://dx.doi.org/10.1002/dad2.12133

Ejemplares similares

(18)F-flortaucipir (AV-1451) tau PET in frontotemporal dementia syndromes
por: Tsai, Richard M., et al.
Publicado: (2019)

Tau PET and multimodal brain imaging in patients at risk for chronic traumatic encephalopathy
por: Lesman-Segev, Orit H, et al.
Publicado: (2019)

Head injury is associated with tau deposition on PET in MCI and AD patients
por: Risacher, Shannon L., et al.
Publicado: (2021)

Head-to-head comparison between plasma p-tau217 and flortaucipir-PET in amyloid-positive patients with cognitive impairment
por: Mundada, Nidhi S., et al.
Publicado: (2023)

Symptomatic amyloid‐related imaging abnormalities in an APOE ε4/ε4 patient treated with aducanumab
por: VandeVrede, Lawren, et al.
Publicado: (2020)

Amyloid duration is associated with preclinical cognitive decline and tau PET
por: Koscik, Rebecca L., et al.
Publicado: (2020)

Deep learning improves utility of tau PET in the study of Alzheimer's disease
por: Zou, James, et al.
Publicado: (2021)

Hippocampal subfield imaging and fractional anisotropy show parallel changes in Alzheimer's disease tau progression using simultaneous tau‐PET/MRI at 3T
por: Carlson, Mackenzie L., et al.
Publicado: (2021)

Tau PET following acute TBI: Off-target binding to blood products, tauopathy, or both?
por: Butler, Tracy, et al.
Publicado: (2022)

Flortaucipir (tau) PET in LGI1 antibody encephalitis
por: Day, Gregory S., et al.
Publicado: (2021)

Normalization of CSF pTau measurement by Aβ(40) improves its performance as a biomarker of Alzheimer’s disease
por: Guo, Tengfei, et al.
Publicado: (2020)

Untangling tau imaging
por: Villemagne, Victor L., et al.
Publicado: (2016)

A multicenter comparison of [(18)F]flortaucipir, [(18)F]RO948, and [(18)F]MK6240 tau PET tracers to detect a common target ROI for differential diagnosis
por: Leuzy, Antoine, et al.
Publicado: (2021)

Staging of amyloid β, t-tau, regional atrophy rates, and cognitive change in a nondemented cohort: Results of serial mediation analyses
por: Fletcher, Evan, et al.
Publicado: (2018)

Qualitative and quantitative assessment of self-reported cognitive difficulties in nondemented elders: Association with medical help seeking, cognitive deficits, and β-amyloid imaging
por: La Joie, Renaud, et al.
Publicado: (2016)

Flortaucipir tau PET imaging in semantic variant primary progressive aphasia
por: Makaretz, Sara J, et al.
Publicado: (2018)

Tau pathology in cognitively normal older adults
por: Ziontz, Jacob, et al.
Publicado: (2019)

Expanding the phenotypic associations of globular glial tau subtypes
por: Burrell, James R., et al.
Publicado: (2016)

In vivo coupling of tau pathology and cortical thinning in Alzheimer's disease
por: Mak, Elijah, et al.
Publicado: (2018)

Role of tau deposition in early cognitive decline in Down syndrome
por: Hartley, Sigan L., et al.
Publicado: (2022)

Cerebrovascular stiffness and flow dynamics in the presence of amyloid and tau biomarkers
por: Rivera‐Rivera, Leonardo A., et al.
Publicado: (2021)

Association between neurite metrics and tau/inflammatory pathology in Alzheimer's disease
por: Sone, Daichi, et al.
Publicado: (2020)

Memory concerns in the early Alzheimer's disease prodrome: Regional association with tau deposition
por: Swinford, Cecily G., et al.
Publicado: (2018)

Cortical atrophy and amyloid and tau deposition in Down syndrome: A longitudinal study
por: Padilla, Concepcion, et al.
Publicado: (2022)

Critical review of the Appropriate Use Criteria for amyloid imaging: Effect on diagnosis and patient care
por: Apostolova, Liana G., et al.
Publicado: (2016)

CSF glucose tracks regional tau progression based on Alzheimer's disease risk factors
por: Pappas, Colleen, et al.
Publicado: (2020)

In vivo network models identify sex differences in the spread of tau pathology across the brain
por: Shokouhi, Sepideh, et al.
Publicado: (2020)

Ictal PET in presurgical workup of refractory extratemporal epilepsy
por: Nooraine, Javeria, et al.
Publicado: (2013)

Image-level trajectory inference of tau pathology using variational autoencoder for Flortaucipir PET
por: Hong, Jimin, et al.
Publicado: (2022)

Cryo-EM Structures of Chronic Traumatic Encephalopathy Tau Filaments with PET Ligand Flortaucipir
por: Shi, Yang, et al.
Publicado: (2023)

Peri‐arterial pathways for clearance of α‐Synuclein and tau from the brain: Implications for the pathogenesis of dementias and for immunotherapy
por: Nimmo, Jacqui, et al.
Publicado: (2020)

Olfactory identification in subjective cognitive decline and mild cognitive impairment: Association with tau but not amyloid positron emission tomography
por: Risacher, Shannon L., et al.
Publicado: (2017)

Longitudinal trajectories of amyloid deposition, cortical thickness, and tau in Down syndrome: A deep-phenotyping case report
por: Mak, Elijah, et al.
Publicado: (2019)

Monoamine oxidase binding not expected to significantly affect [(18)F]flortaucipir PET interpretation
por: Wright, Justin P., et al.
Publicado: (2022)

Added value of amyloid PET in individualized risk predictions for MCI patients
por: van Maurik, Ingrid S., et al.
Publicado: (2019)

Utility of perfusion PET measures to assess neuronal injury in Alzheimer's disease
por: Joseph-Mathurin, Nelly, et al.
Publicado: (2018)

Preoperative [(11)C]methionine PET to personalize treatment decisions in patients with lower-grade gliomas
por: Ninatti, Gaia, et al.
Publicado: (2022)

Clinical use of amyloid-positron emission tomography neuroimaging: Practical and bioethical considerations
por: Witte, Michael M., et al.
Publicado: (2015)

Relationships between flortaucipir PET tau binding and amyloid burden, clinical diagnosis, age and cognition
por: Pontecorvo, Michael J., et al.
Publicado: (2017)

International consensus on the use of tau PET imaging agent (18)F-flortaucipir in Alzheimer’s disease
por: Tian, Mei, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_0uu4st9jo90gr9tk7mr59tbvbm